Patents/Assignees

GLAXOSMITHKLINE BIOLOGICALS SA

101 patents in portfolio

US12138307utility2024
Saponin Extraction
0 cites
US12139512utility2024
Pre-fusion RSV F Antigens
0 cites
US12128096utility2024
Immunogenic Composition
0 cites
US12128094utility2024
Immunogenic Compositions Comprising Omvs, an Acellular Pertussis Antigen, a Tetanus Toxoid and a Diphtheria Toxoid
0 cites
US12109259utility2024
Vaccines for Neisseria Gonorrhoeae
0 cites
US12083174utility2024
Immunogenic Compositions and Uses Thereof
0 cites
US12076352utility2024
Immunogenic Composition
0 cites
US12064480utility2024
Immunigenic Alpha-branched Trehalose-diesters
0 cites
US12036285utility2024
Immunogenic Conjugates and Use Thereof
0 cites
US12016919utility2024
Methods for Manufacturing an Adjuvant
0 cites
US12018044utility2024
RNA Purification Methods
0 cites
US12005109utility2024
Multi-functionalized Nomv Conjugates
0 cites
US11998579utility2024
Immunogenic Composition
0 cites
US11986518utility2024
Immunogenic Compositions
0 cites
US11957749utility2024
Hepatitis B Immunization Regimen and Compositions
0 cites
US11959092utility2024
Process for the Manipulation of Nucleic Acids
0 cites
US11951161utility2024
Methods for Inducing an Immune Response
0 cites
US11944675utility2024
Bioconjugates Made from Recombinant N-glycosylated Proteins from Procaryotic Cells
0 cites
US11939357utility2024
Modified Meningococcal Fhbp Polypeptides
0 cites
US11932669utility2024
Modified Cytomegalovirus Proteins and Stabilized Complexes
0 cites

← PreviousPage 2 of 6Next →